Physician profile
Michael C Wray
NPI 1225391857
$724.16
in general payments reported to CMS, 2019-2025
19 companies · $44.60 in 2025
The $44.60 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2025: $44.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $115.37 | 2019 | |
| Amgen INC. | $91.83 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $57.44 | 2019 | |
| Astellas Pharma US INC | $52.82 | 2019 | |
| Glaxosmithkline, LLC. | $49.76 | 2019 | |
| Pfizer INC. | $48.70 | 2019 | |
| Saluda Medical Americas, INC. | $44.60 | 2025 | Evoke |
| Takeda Pharmaceuticals U.S.A., INC. | $38.85 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.67 | 2019 | |
| Lilly USA, LLC | $38.16 | 2019 | |
| Shire North American Group INC | $26.46 | 2019 | |
| Allergan, INC. | $24.91 | 2019 | |
| Janssen Pharmaceuticals, INC | $22.93 | 2019 | |
| Sanofi Pasteur INC. | $13.63 | 2019 | |
| Radius Health, INC. | $13.23 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $12.87 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.88 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.11 | 2019 | |
| Merck Sharp & Dohme LLC | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.